抗凝逆转药物市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00004954
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 154
Buy Now

[研究报告]抗凝逆转药物市场预计将从2019年的92255万美元增至2027年的227654万美元;预计2020年至2027年该市场将以12.6%的复合年增长率增长。


在某些情况下,例如计划外手术、抗凝治疗过量,需要抗凝逆转药物来逆转抗凝效果和不受控制的出血。抗凝逆转药物用于治疗静脉血栓栓塞、心房颤动 (AF)、机械瓣膜置换术和其他凝血障碍(例如抗磷脂抗体综合征和 V 因子莱顿)等疾病。抗凝逆转药物市场的增长主要归因于心房颤动(AFib)和中风患病率上升等因素。然而,抗凝逆转药物的高成本限制了市场增长。

抗凝逆转药物利润丰厚的区域市场


市场洞察

心房颤动(AFib)患病率上升

口服抗凝剂广泛使用,对于预防血栓栓塞非常有效AFib 患者中。然而,使用抗凝剂可能会导致 AFib 患者出血;因此,使用抗凝逆转药物来预防出血。

根据美国疾病控制与预防中心 (CDC) 的数据,2018 年,在美国,约 175,326 份死亡证明中提到了 AFib,并且是其中约 25,845 人死亡的主要原因。此外,还预计到 2030 年,美国将有 1210 万人患有 AFib。

此外,根据欧洲心脏病学会 (ESC) 的数据,2016 年,65 岁以上的人将有 760 万人在欧盟,患有心房颤动的人预计到 2060 年,这一数字将增加 89%,达到 1440 万。同样,根据中风协会:2017 年国家状况,英国有超过 100 万人患有心房颤动。颤动。

因此,全球心房颤动的高患病率可能有利于市场的增长。

基于产品的见解

根据产品,抗凝逆转药物市场分为凝血酶原复合物浓缩物、维生素 K、鱼精蛋白、氨甲环酸、idarucizumab 和 AndeXXa。凝血酶原复合物浓缩物细分市场在 2019 年占据最大市场份额;而 AndeXXa 细分市场预计在预测期内的复合年增长率最高。凝血酶原复合物浓缩物被广泛用作新鲜冷冻血浆的可靠且快速的替代品,并控制过度出血。

抗凝逆转药物市场(按产品) 2019年和2027年


基于分销渠道的洞察

基于分销渠道的抗凝逆转药物市场分为医院药房、零售药房等。医院药房细分市场在 2019 年占据最大市场份额,预计在预测期内复合年增长率最高。

战略洞察

产品发布和批准是公司扩大全球足迹和产品组合的常用策略。合作是抗凝逆转药物市场参与者为扩大全球客户群而采取的主要策略之一,这也使他们能够在全球范围内维持其品牌名称。

抗凝逆转药品市场 –按产品

  • 凝血酶原复合物浓缩物
  • 维生素 K
  • 鱼精蛋白
  • 氨甲环酸
  • Idarucizumab< /li>
  • AndeXXa

抗凝逆转药物市场 –按分销渠道划分

  • 医院药房
  • 零售药房
  • 其他

抗凝逆转药物市场按地理位置

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • < li>欧洲
    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 休息欧洲
  • 亚太地区 (APAC)
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • MEA其他地区
  • 南美洲和中美洲< ul>
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区

 

公司简介

  • 勃林格殷格翰国际有限公司
  • 辉瑞公司
  • Octapharma AG
  • Amag Pharmaceuticals, Inc
  • Fresenius Kabi AG
  • Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
  • CSL Limited
  • 中国生物制品有限公司
  • Grifols, SA
  • 上海莱士血液制品有限公司
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What anticoagulant reversal drugs?

Anticoagulant reversal drugs are required to reverse the effect of anticoagulation in certain situations such as unplanned surgery, overdose of anticoagulant therapy, and uncontrolled bleeding. In medical conditions such as venous thromboembolism, atrial fibrillation (AF), mechanical valve replacement, and other coagulation disorders such as antiphospholipid antibody syndrome, Factor V Leiden, anticoagulant reversal drugs are used.

What are the driving factors for the anticoagulant reversal drugs market across the globe?

The factors that are driving growth of the market are rise in prevalence of atrial fibrillation (AFib) and increase in prevalence of stroke are the major factors driving the market growth. However, high cost of anticoagulant reversal drugs is hindering the market growth.

Who are the major players in the anticoagulant reversal drugs market?

The anticoagulant reversal drugs market majorly consists of the players such as Boehringer Ingelheim International GmbH; Pfizer Inc; Octapharma AG; Amag Pharmaceuticals, Inc; Fresenius Kabi AG; Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals); CSL Limited; China Biologic Products, Inc; Grifols, S.A, and Shanghai RAAS Blood Products Co., Ltd. amongst others.

The List of Companies - Anticoagulant Reversal Drugs Market

  1. Boehringer Ingelheim International GmbH
  2. Pfizer Inc.
  3. Octapharma AG
  4. AMAG PHARMACEUTICALS, INC.
  5. Fresenius Kabi AG
  6. Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
  7. CSL Limited
  8. China Biologic Products, Inc
  9. Grifols, S.A.
  10. Shanghai RAAS Blood Products Co.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports